Ligand-modified Biopolymeric Nanoparticles as Efficient Tools for Targeted Cancer Therapy

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Pharmacology

Background:

• Chemotherapy's non-specific distribution causes severe side effects, contributing to high cancer mortality.
• Targeted delivery strategies are crucial for improving cancer treatment outcomes.
• Nanoplatform-based therapies offer a promising approach for specific tumor cell targeting.

Purpose of the Study:

• To review recent advancements in targeted drug and gene delivery systems for cancer therapy.
• To highlight the role of biopolymeric nanoplatforms in enhancing therapeutic efficacy.
• To discuss the application of specific targeting ligands for improved drug localization.

Main Methods:

• Focus on biopolymeric nanoplatforms including liposomes, protein-based nanoparticles (e.g., albumin), and polysaccharide-based nanoparticles (e.g., chitosan, dextran).
• Exploration of targeting moieties such as monoclonal antibodies (mAbs), folic acid (FA), and transferrin (Tf) for ligand decoration.
• Review of recent literature on the design and application of these targeted nanocarriers.

Main Results:

• Biopolymeric nanoplatforms demonstrate biocompatibility, biodegradability, and reduced toxicity.
• Decoration with targeting ligands (mAbs, FA, Tf) enables specific delivery to tumor cells.
• Targeted delivery systems show potential for improved drug and gene delivery efficiency.

Conclusions:

• Biopolymeric nanoplatforms decorated with targeting ligands represent a significant advancement in targeted cancer therapy.
• These strategies offer a viable approach to minimize systemic toxicity and maximize therapeutic impact.
• Further research in this area holds promise for developing more effective and safer cancer treatments.